தீபக் சதா News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from தீபக் சதா. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In தீபக் சதா Today - Breaking & Trending Today

Brickell launches first phase of gel study – BizWest

Brickell launches first phase of gel study – BizWest
bizwest.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bizwest.com Daily Mail and Mail on Sunday newspapers.

Deepak Chadha , Brickell Biotech Inc , Kaken Pharmaceutical Co , Kaken Pharmaceutical , தீபக் சதா , செங்கல் பயோடெக் இன்க் ,

Brickell Biotech Completes Patient Enrollment in U.S. Phase 3 Pivotal Cardigan I Study of Sofpironium Bromide Gel, 15% for the Treatment of Primary Axillary Hyperhidrosis


Published: Apr 27, 2021
- - -
Topline results for Phase 3 Pivotal Cardigan I and Cardigan II clinical studies expected in Q4 2021
BOULDER, Colo., April 27, 2021 (GLOBE NEWSWIRE) Brickell Biotech, Inc. (“Brickell” or the “Company”) (Nasdaq: BBI), a clinical-stage pharmaceutical company focused on developing innovative and differentiated prescription therapeutics for the treatment of debilitating skin diseases, today announced completion of patient enrollment in the Phase 3 pivotal Cardigan I study and that the Cardigan II study has surpassed 50% enrollment. Both studies are evaluating sofpironium bromide gel, 15% in patients with primary axillary (underarm) hyperhidrosis.
“We are encouraged with the progress we are making with our Phase 3 pivotal clinical studies, and we remain on track to report topline results from both studies in the fourth quarter of 2021,” said Deepak Chadha, Chief Research and Development Officer of Brickell. “We continue ....

United States , Nicholas Bodor , Deepak Chadha , Research Professor , Brickell Biotech Inc , Company Nasdaq , International Hyperhidrosis Society , Bodor Laboratories Inc , University Of Florida , Exchange Commission , Chief Research , Development Officer , Hyperhidrosis Disease Severity Measure Axillary , New Drug Application , Bodor Laboratories , Graduate Research Professor Emeritus , Securities Litigation Reform Act , United States Securities , Arch Dermatol Res , Investor Contact , ஒன்றுபட்டது மாநிலங்களில் , தீபக் சதா , ஆராய்ச்சி ப்ரொஃபெஸர் , செங்கல் பயோடெக் இன்க் , நிறுவனம் நாஸ்டாக் , சர்வதேச ஹைப்பர்ஹைட்ரோசிஸ் சமூகம் ,